neostigmine

keemiline ühend

Välised allikad

CAS Registry Number
Reaxys registry number
3615946[3]
PubChem CID
MeSH descriptor ID
D009388

teema nimetus kujul: Neostigmine

UniChem compound ID
UNII
ATC code
KEGG ID
UMLS CUI
MeSH concept ID
NSC number
ATCvet
ChEMBL ID
Freebase
Gran Enciclopèdia Catalana ID
InChIKey
SPLASH
DrugBank ID
ChEBI ID
7514[9][12]

mapping relation type: täpne vaste

InChI
electronic Essential Medicines List medicine ID
Human Metabolome Database ID
OpenAlex ID
BMRB ID
SureChEMBL ID
MeSH tree code
DSSTOX compound identifier
Guide to Pharmacology Ligand ID
DSSTox substance ID
Gran Enciclopèdia Catalana ID (former scheme)
Microsoft Academic ID
Store medisinske leksikon ID
neostigmin[18]

teema nimetus kujul: neostigmin

mapping relation type: täpne vaste

PatientsLikeMe treatment ID
ECHA Substance Infocard ID
ChemSpider ID
NMRShiftDB structure ID
NDF-RT ID
DrugCentral ID
WordNet 3.1 Synset ID
03824383-n[21]
MassBank accession ID
Encyclopædia Britannica Online ID
science/neostigmine

teema nimetus kujul: neostigmine

WikiProjectMed ID
RxNorm ID
Probes And Drugs ID
HSDB ID

üksikjuht nähtusest

type of chemical entity

mille alamklass

monocation

kasutus

keemiline struktuur

mass/kaal

223,144653 aatommassiühik[23]

chemical formula

C₁₂H₁₉N₂O₂⁺[4]

canonical SMILES

CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C[4]

defined daily dose

60 milligram[24]

route of administration: oral administration

2 milligram[24]

route of administration: parenteral route of administration

active ingredient in

Bloxiverz[25]

medical condition treated

bladder disease[26]
myasthenia gravis[26]
urinary retention[26]

significant drug interaction

donepezil[27]

side effect: sinus bradycardia

succinylcholine[28]

side effect: neuromuscular blockade

physically interacts with

Acetylcholinesterase[29]

subjektil on roll: Ensüümiinhibiitor

route of administration

oral administration
subcutaneous injection
intravenous infusion and defusion
conjunctival

subjektil on roll

acetylcholinesterase inhibitor[30][31]
parasympathomimetic drug[31]
essential medicine

Commonsi kategooria

Neostigmine

Viited

  1. 1,0 1,1 1,2 1,3 1,4 Global Substance Registration System, 19. november 2016, inglise keel, neostigmine, 3982TWQ96G
  2. CAS Common Chemistry, 10. aprill 2021, ALWKGYPQUAPLQC-UHFFFAOYSA-N, https://commonchemistry.cas.org/detail?cas_rn=59-99-4
  3. 3,0 3,1 3,2 ChEBI, 3. oktoober 2016, inglise keel, neostigmine, 7514
  4. 4,0 4,1 4,2 4,3 4,4 PubChem, 19. november 2016, inglise keel, 4456, NEOSTIGMINE
  5. 5,0 5,1 5,2 5,3 5,4 5,5 5,6 ALWKGYPQUAPLQC-UHFFFAOYSA-N, InChIKey
  6. 6,0 6,1 UniChem
  7. 7,0 7,1 DrugBank, inglise keel, 17. november 2015, 01400, Neostigmine
  8. 8,0 8,1 ChEBI, 5. oktoober 2016, inglise keel, neostigmine methyl sulfate, 7516
  9. 9,0 9,1 ChEMBL, 19. november 2016, inglise keel, NEOSTIGMINE, CHEMBL278020
  10. Freebase Data Dumps, 28. oktoober 2013
  11. ChEBI release 2020-09-01
  12. International Chemical Identifier, InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1
  13. 13,0 13,1 inferred from InChIKey
  14. OpenAlex, 26. jaanuar 2022, https://docs.openalex.org/download-snapshot/snapshot-data-format
  15. Biological Magnetic Resonance Data Bank, bmse000762, inglise keel
  16. IUPHAR/BPS Guide to PHARMACOLOGY, 19. november 2016, inglise keel, 8993, neostigmine
  17. Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard
  18. Great Norwegian Encyclopedia, 30. mai 2020
  19. ECHA Substance Infocard database, 5. august 2020, 100.305.602, (m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)
  20. ChemSpider, 3. oktoober 2016, inglise keel, 4301, Neostigmine
  21. GF WordNet
  22. Hazardous Substances Data Bank, 10. mai 2021, 28. oktoober 2019, NEOSTIGMINE, 3921
  23. PubChem, 3. oktoober 2016, inglise keel, 4456, NEOSTIGMINE
  24. 24,0 24,1 https://www.whocc.no/atc_ddd_index/?code=N07AA01
  25. RxNorm, 1429278, 14. veebruar 2018
  26. 26,0 26,1 26,2 N0000147942, 13. detsember 2016, NDF-RT, inglise keel
  27. A reference set of clinically relevant adverse drug-drug interactions, hypothetically
  28. A reference set of clinically relevant adverse drug-drug interactions, probably
  29. IUPHAR/BPS Guide to PHARMACOLOGY, 17. august 2016, 8993, inglise keel
  30. N0000147942, 5. märts 2018, NDF-RT
  31. 31,0 31,1 Medical Subject Headings, 15. märts 2018, D009388